Focused on a better future.
Arrayus is a medical technology company developing a non-invasive focused ultrasound therapy platform that will revolutionize the standard of care for patients across a broad range of oncological applications.
Transformative Focused Ultrasound Technology
Replaces scalpel-based surgery
Offers a non-invasive tissue ablation therapy that reduces procedure time and complications, minimizes discomfort and provides rapid recovery on an outpatient basis.
—
Complements chemotherapy, radiation therapy
Can be used with traditional therapy options to enhance treatment efficacy and patient outcomes.
—
Expands treatment options and patient eligibility parameters
Provides novel therapeutic options for patients with previously non-qualifying or inoperable medical diseases.
—
An array of possibilities. Multiple applications—one remarkable device
The Arrayus platform combines focused ultrasound therapy with MRI image guidance and treatment monitoring to enable incisionless procedures as an alternative or complement to traditional surgery, radiation therapy or immunotherapy.
Incorporating over two decades of technical and clinical innovations by global leaders in the field, this multi-modality platform combines the world’s largest clinical therapeutic phased array with advanced visualization and real-time therapy monitoring technology. The result is a fast, safe and effective non-invasive therapy platform with the versatility to treat a range of oncological disorders.
Founder and scientific visionary,
Dr. Kullervo Hynynen.
Dr. Hynynen is the current VP of Research at Sunnybrook Research Institute and a global pioneer in the field of focused ultrasound. His 30+ years of basic and clinical research in this space has resulted in over 350 published papers and 20 patents.
“This technology will benefit millions of patients worldwide by ushering in a new era of cancer treatment”
Our passionate team of engineers, technicians, clinical scientists and business professionals.
Our experienced, multidisciplinary team is working together to build innovative advances in focused ultrasound technology that can deliver meaningful clinical benefit to cancer therapy patients.
Advancing focused ultrasound therapies through strategic research and collaboration partnerships
